At a Glance
| 2-Aminoindane | 3-FMA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 10–20 mg | 20–35 mg |
| Total Duration | 0.5–1.5 hrs | 2.8–6 hrs |
| Routes | oral | oral |
| Effects | 27 documented | 8 documented |
2-Aminoindane, a Stimulants, and 3-FMA, a Entactogen, Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. 2-Aminoindane is classified as a Stimulants while 3-FMA is a Entactogen, Stimulants, meaning they approach altered states through different pharmacological mechanisms. They share 5 documented effects in common, with 22 effects unique to 2-Aminoindane and 3 unique to 3-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2-Aminoindane | 3-FMA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 10–20 mg | 20–35 mg |
| Total Duration | 0.5–1.5 hrs | 2.8–6 hrs |
| Routes | oral | oral |
| Effects | 27 documented | 8 documented |
| Interaction |
| Caution |
| Level | 2-Aminoindane | 3-FMA |
|---|---|---|
| Threshold | 3 mg | 5 mg |
| Light | 5–10 mg | 10–20 mg |
| Common | 10–20 mg | 20–35 mg |
| Strong | 20–40 mg | 35–50 mg |
| Heavy | 40 mg | 50 mg |
2-Aminoindane
3-FMA
Increased cardiovascular strain and neurotoxicity risk